Literature DB >> 8226726

Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling.

S B Waters1, K Yamauchi, J E Pessin.   

Abstract

To examine the role of the insulin receptor substrate-1 (IRS-1) in mediating insulin biological responsiveness, we generated Chinese hamster ovary cell lines expressing antisense IRS-1 RNA. These cells displayed morphological alterations as well as markedly reduced growth rates compared to the parental cells. Furthermore, the antisense IRS-1 cell lines had decreased insulin-stimulated IRS-1 tyrosine phosphorylation, reduced phosphatidylinositol 3-kinase activation, and decreased thymidine incorporation relative to the parental cell line. Insulin-dependent transcriptional regulation of a serum response element/luciferase reporter construct (SRE-Luc) was also reduced in the antisense IRS-1-expressing cell lines. However, co-transfection with a plasmid directing the expression of rat IRS-1 fully restored insulin-stimulated SRE-Luc activity in the IRS-1 antisense cell lines. Thus, the inhibition in insulin signaling was a specific effect of decreased IRS-1 tyrosine phosphorylation. Taken together, these data demonstrate that insulin regulation of mitogenic signaling requires the functional expression of IRS-1 and documents its central importance in the insulin intracellular signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226726

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.

Authors:  J C Brüning; J Winnay; B Cheatham; C R Kahn
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 4.  Role of binding proteins to IRS-1 in insulin signalling.

Authors:  W Ogawa; T Matozaki; M Kasuga
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

7.  The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation.

Authors:  Janet Farhang-Fallah; Varinder K Randhawa; Anjaruwee Nimnual; Amira Klip; Dafna Bar-Sagi; Maria Rozakis-Adcock
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.

Authors:  K Almind; G Inoue; O Pedersen; C R Kahn
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Role of IRS-1-GRB-2 complexes in insulin signaling.

Authors:  M G Myers; L M Wang; X J Sun; Y Zhang; L Yenush; J Schlessinger; J H Pierce; M F White
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.